Dr. Mayanka Singh, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $730.04 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $142.06 | 5 | $0 (2020) |
| ViiV Healthcare Company | $132.61 | 6 | $0 (2024) |
| Allergan Inc. | $120.77 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $81.12 | 4 | $0 (2024) |
| Abbott Laboratories | $77.41 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $28.72 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23.85 | 2 | $0 (2019) |
| Shionogi Inc | $22.26 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $21.79 | 1 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $20.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.02 | 6 | ViiV Healthcare Company ($70.77) |
| 2023 | $179.22 | 9 | ViiV Healthcare Company ($61.84) |
| 2022 | $33.89 | 2 | Janssen Biotech, Inc. ($21.79) |
| 2020 | $90.18 | 2 | PFIZER INC. ($90.18) |
| 2019 | $133.91 | 2 | Allergan Inc. ($120.77) |
| 2018 | $66.07 | 4 | PFIZER INC. ($35.08) |
| 2017 | $106.75 | 3 | Abbott Laboratories ($77.41) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.88 | General |
| 09/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.92 | General |
| 08/26/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: HIV | ||||||
| 03/12/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: HIV | ||||||
| 02/12/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: HIV | ||||||
| 01/29/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: COVID-19 | ||||||
| 08/29/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.31 | General |
| Category: HFCWO | ||||||
| 07/24/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/19/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: HIV | ||||||
| 07/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.09 | General |
| 06/08/2023 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: Infectious Disease | ||||||
| 05/17/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: HIV | ||||||
| 03/10/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: HIV | ||||||
| 02/22/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/13/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/28/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/05/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $71.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $120.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/05/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL BRADY (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: BRADY | ||||||
| 04/26/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 125 | 203 | $49,895 | $17,616 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 93 | $24,180 | $7,969 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 22 | $3,740 | $2,390 | 63.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $8,910 | $2,332 | 26.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 25 | $8,375 | $2,272 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 21 | $2,660 | $1,553 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 24 | $2,030 | $1,101 | 54.3% |
About Dr. Mayanka Singh, M.D
Dr. Mayanka Singh, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1154705697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mayanka Singh, M.D has received a total of $730.04 in payments from pharmaceutical and medical device companies, with $120.02 received in 2024. These payments were reported across 28 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($730.04).
As a Medicare-enrolled provider, Singh has provided services to 125 Medicare beneficiaries, totaling 203 services with total Medicare billing of $17,616. Data is available for 1 year (2023–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Infectious Disease
- Location Greensboro, NC
- Active Since 07/15/2015
- Last Updated 07/14/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1154705697
Products in Payments
- ELIQUIS (Drug) $154.60
- DALVANCE (Drug) $132.87
- Circulatory Support (Device) $77.41
- CABENUVA (Biological) $73.82
- APRETUDE (Biological) $58.79
- DIFICID (Drug) $28.72
- Veklury (Drug) $25.23
- BRILINTA (Drug) $23.85
- Fetroja (Drug) $22.26
- SYMTUZA (Drug) $21.79
- GENERAL BRADY (Device) $20.28
- Mytesi (Drug) $18.22
- SMARTVEST (Device) $16.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Greensboro
Peter Arnold, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $223,872
Dr. Christopher White, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,427
Jon Mugweru, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $7,923
Eugene Bell, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,328
Dr. Matthew Gay, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,240
Stephanie Wolfe, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,597